This clinical trial is being done to evaluate the safety and clinical response of late surfactant treatment with budesonide in extremely preterm infants requiring mechanical ventilation at 7-14 days of age.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Presence or absence of acute clinical deterioration up to 60 minutes after study intervention
Timeframe: up to 60 minutes after study intervention (intervention received within 14 days of life (DOL))
Presence or absence of severe acute clinical deterioration up to 60 minutes after study intervention
Timeframe: up to 60 minutes after study intervention (intervention received within 14 DOL)
Occurrence of pneumothorax needing evacuation up to 48 hours after completion of study intervention
Timeframe: baseline to 48 hours after completion of study intervention (intervention received within 14 DOL)
Occurrence of pulmonary hemorrhages up to 48 hours after completion of study intervention
Timeframe: baseline to 48 hours after completion of study intervention (intervention received within 14 DOL)